Nancy Chan

2.1k total citations · 1 hit paper
55 papers, 868 citations indexed

About

Nancy Chan is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Nancy Chan has authored 55 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Pulmonary and Respiratory Medicine and 13 papers in Cancer Research. Recurrent topics in Nancy Chan's work include Cancer Immunotherapy and Biomarkers (9 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (7 papers). Nancy Chan is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Advanced Breast Cancer Therapies (7 papers) and Cancer Treatment and Pharmacology (7 papers). Nancy Chan collaborates with scholars based in United States, Canada and Spain. Nancy Chan's co-authors include Shridar Ganesan, Zia A. Khan, Jyoti Malhotra, Salma K. Jabbour, Eugenia Girda, Ann W. Silk, Alexandra Kleiman, Gregory Riedlinger, Kristen Spencer and Roman Groisberg and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Clinical Cancer Research.

In The Last Decade

Nancy Chan

46 papers receiving 858 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers

2021 196 citations Matteo Palmeri, Janice M. Mehnert et al. ESMO Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nancy Chan United States	16	373	302	241	208	148	55	868
Stella D’Oronzo Italy	21	594 1.6×	421 1.4×	209 0.9×	176 0.8×	171 1.2×	46	1.1k
I. Bazin Russia	13	424 1.1×	289 1.0×	374 1.6×	195 0.9×	332 2.2×	30	975
Eveline J. Kamping Netherlands	14	191 0.5×	610 2.0×	188 0.8×	145 0.7×	229 1.5×	23	1.2k
Ping Han China	17	168 0.5×	240 0.8×	166 0.7×	133 0.6×	134 0.9×	67	791
Mariana M. Cajaiba United States	16	155 0.4×	470 1.6×	328 1.4×	257 1.2×	166 1.1×	43	923
Gabriele Gamerith Austria	18	507 1.4×	233 0.8×	200 0.8×	92 0.4×	193 1.3×	44	914
Maria Raffaella Ambrosio Italy	18	392 1.1×	303 1.0×	178 0.7×	179 0.9×	221 1.5×	79	962
Alla Lisyanskaya Russia	15	447 1.2×	233 0.8×	132 0.5×	303 1.5×	76 0.5×	49	1.1k
Anne Gentil‐Perret France	20	220 0.6×	531 1.8×	401 1.7×	153 0.7×	252 1.7×	42	961
Jessica D. McDermott United States	18	572 1.5×	389 1.3×	245 1.0×	561 2.7×	149 1.0×	40	1.3k

Countries citing papers authored by Nancy Chan

Since Specialization

Citations

This map shows the geographic impact of Nancy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Chan more than expected).

Fields of papers citing papers by Nancy Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nancy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Chan. The network helps show where Nancy Chan may publish in the future.

Co-authorship network of co-authors of Nancy Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Nancy Chan. A scholar is included among the top collaborators of Nancy Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nancy Chan. Nancy Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, Alexandra, Anthony Rhoads, Erica L. Mayer, et al.. (2025). Evolving incidence patterns for locally advanced operable breast cancer by receptor status: SEER 2010–2021. npj Breast Cancer. 11(1). 127–127.

Filler, Guido, et al.. (2025). Acute kidney injury with cast nephropathy following creatine loading in a 17-year-old. Pediatric Nephrology. 40(10). 3089–3092.

Spencer, Kristen, Joseph Aisner, Mark N. Stein, et al.. (2023). A phase I trial of riluzole and sorafenib in patients with advanced solid tumors: CTEP #8850. Oncotarget. 14(1). 302–315. 5 indexed citations

Girda, Eugenia, June Y. Hou, David L. Nelson, et al.. (2022). Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer. International Journal of Gynecological Cancer. 32(8). 1032–1038. 8 indexed citations

Malhotra, Jyoti, Bríd M. Ryan, Nancy Chan, et al.. (2022). Clinical outcomes and immune phenotypes associated with STK11 co-occurring mutations in non-small cell lung cancer. Journal of Thoracic Disease. 14(6). 1772–1783. 14 indexed citations

Silk, Ann W., Biren Saraiya, Roman Groisberg, et al.. (2022). A phase Ib dose-escalation study of troriluzole (BHV-4157), an oral glutamatergic signaling modulator, in combination with nivolumab in patients with advanced solid tumors. European journal of medical research. 27(1). 107–107. 13 indexed citations

Matsuda, Kant, Gregory Riedlinger, Levi Sokol, et al.. (2021). Durable Response to PD1 Inhibitor Pembrolizumab in a Metastatic, Metaplastic Breast Cancer. Case Reports in Oncology. 14(2). 931–937. 10 indexed citations

Tan, Antoinette R., Nancy Chan, Brian F. Kiesel, et al.. (2021). A phase I study of veliparib with cyclophosphamide and veliparib combined with doxorubicin and cyclophosphamide in advanced malignancies. Cancer Chemotherapy and Pharmacology. 89(1). 49–58. 2 indexed citations

Palmeri, Matteo, Janice M. Mehnert, Ann W. Silk, et al.. (2021). Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 7(1). 100336–100336. 196 indexed citations breakdown →

10.

Campagnolo, Carla, et al.. (2020). TP63‐mutation as a cause of prenatal lethal multicystic dysplastic kidneys. Molecular Genetics & Genomic Medicine. 8(11). e1486–e1486. 3 indexed citations

11.

Bahleda, Rastislav, Antoîne Italiano, Cinta Hierro, et al.. (2019). Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors. Clinical Cancer Research. 25(16). 4888–4897. 187 indexed citations

12.

Stein, Mark N., Nancy Chan, Ann W. Silk, et al.. (2017). Anticancer and immunostimulatory activity of the imipridone ONC201, a selective DRD2 antagonist, in advanced cancer patients.. Journal of Clinical Oncology. 35(15_suppl). 2586–2586. 1 indexed citations

13.

Soria, Jean‐Charles, Antoîne Italiano, Andrés Cervantes, et al.. (2016). Safety and activity of the pan–fibroblast growth factor receptor (FGFR) inhibitor erdafitinib in phase 1 study patients with advanced urothelial carcinoma. Annals of Oncology. 27. vi269–vi269. 13 indexed citations

14.

Chakrabarti, Rana, et al.. (2012). Intrinsic regulation of hemangioma involution by platelet-derived growth factor. Cell Death and Disease. 3(6). e328–e328. 19 indexed citations

15.

Kleiman, Alexandra, et al.. (2012). Elevated IGF2 prevents leptin induction and terminal adipocyte differentiation in hemangioma stem cells. Experimental and Molecular Pathology. 94(1). 126–136. 20 indexed citations

16.

Kleiman, Alexandra, et al.. (2012). Evolution of hemangioma endothelium. Experimental and Molecular Pathology. 93(2). 264–272. 31 indexed citations

17.

Sadler, Georgia Robins, et al.. (2009). Then and Now: Comparison of Baseline Breast Cancer Screening Rates at 2 Time Intervals. Journal of Cancer Education. 24(1). 4–9. 6 indexed citations

18.

Chan, Nancy, et al.. (2007). Ectopic breast tissue presenting as an anal polyp.. PubMed. 50(6). E23–4. 11 indexed citations

19.

Dakhama, Azzeddine, Andrew M. Bramley, Nancy Chan, et al.. (1999). Effect of respiratory syncytial virus on subsequent allergic sensitization to ovalbumin in guinea‐pigs. European Respiratory Journal. 13(5). 976–976. 23 indexed citations

20.

Nichol, Kerry A., Nancy Chan, D. F. Davey, & Max R. Bennett. (1995). Location of nitric oxide synthase in the developing avian ciliary ganglion. Journal of the Autonomic Nervous System. 51(2). 91–102. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact